Related Experiment Videos
[Perfusion lung scintigraphy in primary pulmonary hypertension]
Y Ogawa1, T Nishimura, S Kumita
1Department of Diagnostic Radiology, National Cardiovascular Center, Osaka.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|February 1, 1991
Summary
Perfusion lung scans can predict prognosis in primary pulmonary hypertension (PPH). A mottled pattern on scans indicates higher mean pulmonary arterial pressure and lower survival rates in PPH patients.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Diagnostic Imaging
Background:
- Primary pulmonary hypertension (PPH) is a severe condition affecting pulmonary arteries.
- Accurate prognostic indicators are crucial for managing PPH patients.
- Perfusion lung scans offer a non-invasive method to assess pulmonary vasculature.
Purpose of the Study:
- To evaluate the utility of perfusion lung scan patterns in predicting prognosis for patients with PPH.
- To correlate specific perfusion lung scan patterns with hemodynamic and survival data in PPH.
Main Methods:
- Fifteen PPH patients were categorized into two groups based on perfusion lung scan patterns: mottled (n=8) and non-mottled (n=7).
- Comparison of mean pulmonary arterial pressure (mean PAP), right ventricular ejection fraction (RVEF), arterial oxygen tension (PaO2), and alveolar-arterial oxygen difference (A-aDo2) between groups.
- Survival rates were analyzed in relation to the perfusion lung scan patterns.
Main Results:
- The mottled pattern group exhibited significantly higher mean PAP compared to the non-mottled group.
- No significant differences were observed in RVEF, PaO2, or A-aDo2 between the two groups.
- Patients with the mottled pattern demonstrated a significantly lower survival rate (p < 0.05).
Conclusions:
- Perfusion lung scan patterns, particularly the mottled pattern, are valuable for assessing prognosis in PPH.
- The mottled pattern is associated with increased pulmonary arterial pressure and reduced survival.
- This imaging technique aids in risk stratification and clinical management of PPH.